🟢 Trulieve Cannabis is trading 10% up in pre-market with no clear company-specific catalyst

Trulieve Cannabis is trading at $11.00, up 9.89%, with no clear company-specific announcement explaining the October 19 pre-market rise.

• Recent coverage highlights the paused federal rescheduling process, which has weighed on cannabis-sector sentiment.
• Major U.S. indexes were higher, offering a possible broader-market backdrop; no source directly links their gains to Trulieve.
• The previously announced $65 million mortgage repayment is not a new October 19 catalyst.